检索结果 - Craig Fancourt

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Pharmacokinetics, Safety, and Efficacy of Letermovir for Cytomegalovirus Prophylaxis in Adolescent Hematopoietic Cell Transplantation Recipients

    Pharmacokinetics, Safety, and Efficacy of Letermovir for Cytomegalovirus Prophylaxis in Adolescent Hematopoietic Cell Transplantation Recipients 由 Andreas H. Groll, Johannes H. Schulte, Bülent Antmen, Christopher Fraser, Valerie Teal, Barbara Haber, Luzelena Caro, Jacqueline B. McCrea, Craig Fancourt, Mayankbhai Patel, Karsten Menzel, Cyrus Badshah

    出版 2024
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)

    A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML) 由 Farhad Ravandi, Ivana Gojo, Mrinal M. Patnaik, Mark D. Minden, Hagop M. Kantarjian, Amy O. Johnson‐Levonas, Craig Fancourt, Raymond W. Lam, Mary Jones, Clayton D. Knox, Shelonitda Rose, Payal Patel, Raoul Tibes

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid Tumors

    Phase I Trial of the Human Double Minute 2 Inhibitor MK-8242 in Patients With Advanced Solid Tumors 由 Andrew J. Wagner, Udai Banerji, Amit Mahipal, Neeta Somaiah, Heather A. Hirsch, Craig Fancourt, Amy O. Johnson‐Levonas, Raymond W. Lam, Amy Meister, Giuseppe Lo Russo, Clayton D. Knox, Shelonitda Rose, David S. Hong

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: